Imatinib Mesylate Therapy Improves Survival in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in the Chronic Phase: Comparison with Historic Data

Hagop M. Kantarjian*, Susan O'Brien, Jorge Cortes, Francis J. Giles, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, William Wierda, Michael Keating, Moshe Talpaz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib Mesylate Therapy Improves Survival in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in the Chronic Phase: Comparison with Historic Data'. Together they form a unique fingerprint.

Medicine & Life Sciences